CELGENE CORP

CELGENE CORP

Displaying 10 out of 5 results

  1. New Content Item

    US patent court rejects Alvogen's challenge for Celgene's Revlimid

  2. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers tells opponents Celgene deal is 'best path'

    U.S. drugmaker Bristol-Myers Squibb urged shareholders on Wednesday to support its planned takeover of Celgene Corp, as it faces opposition to the ...
  3. New Content Item

    Celgene profit beats as psoriasis drug sales surge

  4. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at building i

    Celgene, Bristol-Myers set US$2.2 billion termination fee for their mega deal

    Celgene Corp and Bristol-Myers Squibb Co will have to pay US$2.2 billion if either of the drugmakers walks away from their US$74 billion merger ...
  5. Bristol-Myers Squibb

    Bristol-Myers to buy Celgene for US$74 billion in largest biopharma deal

    Cancer drugmaker Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about US$74 billion in a cash-and-stock deal.